new glp 1 medications Novo's Wegovy becomes first GLP-1 drug approved for MASH What to know about the

Gastrointestinal Injuries and Complications Gastrointestinal injuries represent the primary focus of MDL 3094 litigation, with thousands of plaintiffs alleging that GLP-1 medications caused severe and sometimes permanent damage to their digestive systems

TB-500: The Cellular Migration and Remodeling Director TB-500 is a synthetic form of thymosin beta-4, a peptide associated with cell migration and tissue repair

The group discussed alternative accommodations, tech-enabled solutions and other exciting topics in hospitality real estate in front of a packed room of commercial real estate professionals in NYC

doi: 10.2337/db17-1280